ArticleStem cell research & therapy2019

Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice.

Shinichiro Kuroshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.